Dick Stockelberg

5.0k total citations · 2 hit papers
66 papers, 3.6k citations indexed

About

Dick Stockelberg is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Dick Stockelberg has authored 66 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 26 papers in Public Health, Environmental and Occupational Health and 12 papers in Oncology. Recurrent topics in Dick Stockelberg's work include Acute Myeloid Leukemia Research (24 papers), Acute Lymphoblastic Leukemia research (21 papers) and Platelet Disorders and Treatments (18 papers). Dick Stockelberg is often cited by papers focused on Acute Myeloid Leukemia Research (24 papers), Acute Lymphoblastic Leukemia research (21 papers) and Platelet Disorders and Treatments (18 papers). Dick Stockelberg collaborates with scholars based in Sweden, Estonia and United States. Dick Stockelberg's co-authors include Martin Höglund, Anders Wåhlin, Gunnar Juliusson, Lars Möllgård, Åsa Rangert Derolf, Ulf Tidefelt, Oliver A. Cornely, David Helfgott, Sylvain Lehmann and Mario Petrini and has published in prestigious journals such as New England Journal of Medicine, Blood and Cancer.

In The Last Decade

Dick Stockelberg

65 papers receiving 3.5k citations

Hit Papers

Posaconazole vs. Fluconazole or Itraconazole Prophylaxis ... 2007 2026 2013 2019 2007 2008 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
    2007 1.3k citations Dick Stockelberg et al. profile →
  2. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
    2008 683 citations Gunnar Juliusson, Petar Antunović et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dick Stockelberg Sweden 22 1.7k 1.2k 1.1k 763 741 66 3.6k
Stefano Tarantolo United States 24 1.1k 0.6× 1.1k 0.9× 958 0.8× 918 1.2× 434 0.6× 79 3.3k
Chantal Doyen Belgium 23 1.5k 0.9× 811 0.7× 656 0.6× 1.8k 2.3× 1.1k 1.5× 74 3.6k
Gerlinde Egerer Germany 41 1.2k 0.7× 927 0.8× 677 0.6× 1.4k 1.8× 835 1.1× 181 4.6k
B Gibson United Kingdom 27 824 0.5× 395 0.3× 412 0.4× 472 0.6× 348 0.5× 58 2.4k
Yi‐Bin Chen United States 35 2.1k 1.2× 557 0.5× 683 0.6× 1.5k 2.0× 1.1k 1.5× 197 4.9k
Liat Vidal Israel 29 525 0.3× 972 0.8× 506 0.4× 1.1k 1.5× 256 0.3× 82 3.1k
William P. Vaughan United States 30 1.0k 0.6× 408 0.3× 289 0.3× 868 1.1× 364 0.5× 89 2.8k
Axel Glasmacher Germany 39 906 0.5× 1.8k 1.5× 1.7k 1.5× 1.8k 2.4× 600 0.8× 117 4.7k
Roy S. Weiner United States 27 1.1k 0.6× 372 0.3× 249 0.2× 798 1.0× 507 0.7× 91 2.9k
David D. Hurd United States 35 2.4k 1.4× 381 0.3× 196 0.2× 1.6k 2.0× 1.2k 1.6× 159 4.8k

Countries citing papers authored by Dick Stockelberg

Since Specialization
Citations

This map shows the geographic impact of Dick Stockelberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dick Stockelberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dick Stockelberg more than expected).

Fields of papers citing papers by Dick Stockelberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dick Stockelberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dick Stockelberg. The network helps show where Dick Stockelberg may publish in the future.

Co-authorship network of co-authors of Dick Stockelberg

This figure shows the co-authorship network connecting the top 25 collaborators of Dick Stockelberg. A scholar is included among the top collaborators of Dick Stockelberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dick Stockelberg. Dick Stockelberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nilsson, Christer, Erik Hulegårdh, Hege Garelius, et al.. (2019). Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting. Biology of Blood and Marrow Transplantation. 25(9). 1770–1778. 22 indexed citations
2.
Hulegårdh, Erik, Erik Holmberg, Katrin Palk, et al.. (2016). Acute de novo Leukemia in Estonia and Western Sweden 1982-2006: Positive Trend in the Survival of Acute Leukemia over 25 Years. Acta Haematologica. 136(3). 167–173.
3.
Juliusson, Gunnar, Karin Karlsson, Vladimir Lazarević, et al.. (2011). Hematopoietic stem cell transplantation rates and long‐term survival in acute myeloid and lymphoblastic leukemia. Cancer. 117(18). 4238–4246. 46 indexed citations
4.
Palk, Katrin, Krista Vaht, Hele Everaus, et al.. (2010). The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1997–2001: A survey of patients aged ≥65 years. Cancer Epidemiology. 34(1). 24–28. 3 indexed citations
5.
Andersson, Inger, Karin Ahlberg, Dick Stockelberg, & Lars‐Olof Persson. (2010). Patients' perception of health-related quality of life during the first year after autologous and allogeneic stem cell transplantation. European Journal of Cancer Care. 20(3). 368–379. 20 indexed citations
6.
Skovbjerg, Susann, Christina Welinder‐Olsson, Nahid Kondori, et al.. (2009). Optimization of the detection of microbes in blood from immunocompromised patients with haematological malignancies. Clinical Microbiology and Infection. 15(7). 680–683. 14 indexed citations
7.
Andersson, Inger, Karin Ahlberg, Dick Stockelberg, Mats Brune, & Lars‐Olof Persson. (2009). Health-Related Quality of Life in Patients Undergoing Allogeneic Stem Cell Transplantation After Reduced Intensity Conditioning Versus Myeloablative Conditioning. Cancer Nursing. 32(4). 325–334. 34 indexed citations
8.
Juliusson, Gunnar, Petar Antunović, Åsa Rangert Derolf, et al.. (2008). Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood. 113(18). 4179–4187. 683 indexed citations breakdown →
9.
Johansson, J-E, et al.. (2008). Gut protection by palifermin during autologous haematopoietic SCT. Bone Marrow Transplantation. 43(10). 807–811. 15 indexed citations
10.
Andersson, Inger, Marianne Jensen Hjermstad, Dick Stockelberg, & Lars‐Olof Persson. (2008). Health Related Quality of Life in stem cell transplantation: Clinical and psychometric validation of the questionnaire module, High Dose Chemotherapy (HDC-19). Acta Oncologica. 47(2). 275–285. 10 indexed citations
11.
12.
Wei, Yuan, Mats Hardling, Bob Olsson, et al.. (2006). Not all imatinib resistance in CML are BCR-ABL kinase domain mutations. Annals of Hematology. 85(12). 841–847. 19 indexed citations
13.
Palk, Katrin, Hele Everaus, Tiiu Aareleid, et al.. (2004). The incidence and survival of acute de novo leukaemias in Estonia and in a well‐defined region of western Sweden during 1982–1996: a survey of patients aged ≥65 years. Journal of Internal Medicine. 256(1). 79–85. 7 indexed citations
14.
15.
Stockelberg, Dick, et al.. (2003). [CPP (Cost Per Patient) is functioning well in the everyday care. The myeloma care program in Vastra Gotaland--an illustrative example].. PubMed. 100(42). 3316–8. 1 indexed citations
16.
17.
Andréasson, Björn, Göran Lindstedt, Dick Stockelberg, Hans Wadenvik, & Jack Kutti. (2001). The Relation Between Plasma Thrombopoietin and Erythropoietin Concentrations in Polycythaemia Vera and Essential Thrombocythaemia. Leukemia & lymphoma. 41(5-6). 579–584. 5 indexed citations
18.
Hou, Ming, Jan Carneskog, Ulf‐Henrik Mellqvist, et al.. (1998). Impact of endogenous thrombopoietin levels on the differential diagnosis of essential thrombocythaemia and reactive thrombocytosis. European Journal Of Haematology. 61(2). 119–122. 20 indexed citations
19.
Hou, Ming, Dick Stockelberg, Jack Kutti, & Hans Wadenvik. (1997). Immunoglobulins targeting both GPIIb/IIIa and GPIb/IX in chronic idiopathic thrombocytopenic purpura (ITP): evidence for at least two different IgG antibodies. British Journal of Haematology. 98(1). 64–67. 22 indexed citations
20.
Stockelberg, Dick, et al.. (1995). Effects of Erwinia‐asparaginase on the coagulation system. European Journal Of Haematology. 55(5). 289–293. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano Tarantolo Breakdown of academic impact, for papers by Chantal Doyen Breakdown of academic impact, for papers by Gerlinde Egerer Breakdown of academic impact, for papers by B Gibson Breakdown of academic impact, for papers by Yi‐Bin Chen Breakdown of academic impact, for papers by Liat Vidal Breakdown of academic impact, for papers by William P. Vaughan Breakdown of academic impact, for papers by Axel Glasmacher Breakdown of academic impact, for papers by Roy S. Weiner Breakdown of academic impact, for papers by David D. Hurd
Rankless by CCL
2026